Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R Knapp

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2024
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated CytotoxicityZachary L Z Hay, Dale D Kim, Jennifer M Cimons, et al.
Journal of Leukocyte Biology|November 6, 2020
MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cellsDaniel A Pollyea, Hyun Min Kim, Brett M Stevens, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
CHD4 is essential for transcriptional repression and lineage progression in B lymphopoiesisTessa Arends, Carissa Dege, Alexandra Bortnick, et al.
Molecular Oncology|May 29, 2016
Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitorsLei Zhang, Maria B Hapon, Alicia A Goyeneche, et al.
JCI Insight|March 22, 2022
CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisonsXi Zhang, Camille M Moore, Laura D Harmacek, et al.
Leukemia|August 17, 2023
Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxisNatalia J Gurule, Kenneth C Malcolm, Chelsea Harris, et al.
Breast Cancer Research : BCR|September 19, 2015
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S Elsarraj, Yan Hong, Kelli E Valdez, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2024
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated CytotoxicityZachary L Z Hay, Dale D Kim, Jennifer M Cimons, et al.
Journal of Leukocyte Biology|November 6, 2020
MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cellsDaniel A Pollyea, Hyun Min Kim, Brett M Stevens, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
CHD4 is essential for transcriptional repression and lineage progression in B lymphopoiesisTessa Arends, Carissa Dege, Alexandra Bortnick, et al.
Molecular Oncology|May 29, 2016
Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitorsLei Zhang, Maria B Hapon, Alicia A Goyeneche, et al.
JCI Insight|March 22, 2022
CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisonsXi Zhang, Camille M Moore, Laura D Harmacek, et al.
Leukemia|August 17, 2023
Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxisNatalia J Gurule, Kenneth C Malcolm, Chelsea Harris, et al.
Breast Cancer Research : BCR|September 19, 2015
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionHanan S Elsarraj, Yan Hong, Kelli E Valdez, et al.
Pageof 2